Stock 000518 JIANGSU SIHUAN BIOENGINEERING CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jiangsu Sihuan Bioengineering Co., Ltd

Equities

000518

CNE0000001P8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
2.02 CNY +2.02% Intraday chart for Jiangsu Sihuan Bioengineering Co., Ltd +1.51% -39.16%
29/04 Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,562 3,737 5,271 3,737 3,264 3,418
Enterprise Value (EV) 1 3,593 3,700 5,233 3,750 3,284 3,447
P/E ratio -121 x 261 x 193 x -107 x -66.9 x -45.4 x
Yield - - - - - -
Capitalization / Revenue 9.01 x 8.94 x 10.4 x 11 x 12.1 x 14.5 x
EV / Revenue 9.08 x 8.85 x 10.4 x 11 x 12.2 x 14.6 x
EV / EBITDA -221 x 81.9 x 92.6 x -186 x -110 x -69.4 x
EV / FCF 453 x 57.4 x 923 x 1,333 x 128 x 165 x
FCF Yield 0.22% 1.74% 0.11% 0.08% 0.78% 0.61%
Price to Book 5.95 x 6.09 x 8.23 x 6.17 x 5.86 x 7.1 x
Nbr of stocks (in thousands) 10,29,556 10,29,556 10,29,556 10,29,556 10,29,556 10,29,556
Reference price 2 3.460 3.630 5.120 3.630 3.170 3.320
Announcement Date 15/04/19 24/04/20 16/04/21 27/04/22 26/04/23 29/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 395.5 417.9 505.4 340.1 270.1 235.4
EBITDA 1 -16.24 45.17 56.52 -20.17 -29.91 -49.65
EBIT 1 -27.77 26.32 38.24 -38.83 -49.56 -67.21
Operating Margin -7.02% 6.3% 7.57% -11.42% -18.34% -28.55%
Earnings before Tax (EBT) 1 -30.29 27.85 36.44 -39.71 -53.61 -79.43
Net income 1 -29.44 14.33 27.3 -34.79 -48.79 -75.27
Net margin -7.44% 3.43% 5.4% -10.23% -18.06% -31.97%
EPS 2 -0.0286 0.0139 0.0265 -0.0338 -0.0474 -0.0731
Free Cash Flow 1 7.932 64.42 5.67 2.813 25.68 20.88
FCF margin 2.01% 15.42% 1.12% 0.83% 9.51% 8.87%
FCF Conversion (EBITDA) - 142.62% 10.03% - - -
FCF Conversion (Net income) - 449.52% 20.77% - - -
Dividend per Share - - - - - -
Announcement Date 15/04/19 24/04/20 16/04/21 27/04/22 26/04/23 29/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 30.6 - - 12.8 20.4 28.8
Net Cash position 1 - 37.1 38.6 - - -
Leverage (Debt/EBITDA) -1.882 x - - -0.6329 x -0.6822 x -0.5809 x
Free Cash Flow 1 7.93 64.4 5.67 2.81 25.7 20.9
ROE (net income / shareholders' equity) -4.51% 2.69% 4.11% -6.3% -8.59% -14.5%
ROA (Net income/ Total Assets) -1.87% 1.79% 2.75% -2.99% -4.03% -6.01%
Assets 1 1,576 802.1 993.5 1,163 1,211 1,253
Book Value Per Share 2 0.5800 0.6000 0.6200 0.5900 0.5400 0.4700
Cash Flow per Share 2 0.0400 0.0500 0.0500 0.0400 0.0300 0.0200
Capex 1 6.07 15.2 8.7 7.69 8.47 8.19
Capex / Sales 1.54% 3.64% 1.72% 2.26% 3.14% 3.48%
Announcement Date 15/04/19 24/04/20 16/04/21 27/04/22 26/04/23 29/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Biopharmaceuticals

1st Jan change Capi.
JIANGSU SIHUAN BIOENGINEERING CO., LTD Stock Jiangsu Sihuan Bioengineering Co., Ltd
-39.16% 286M
CSL LIMITED Stock CSL Limited
+3.20% 94.76B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-3.68% 37.58B
BIOGEN INC. Stock Biogen Inc.
-11.61% 33.3B
UCB Stock UCB
+74.21% 27.92B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-13.40% 15.85B
INCYTE CORPORATION Stock Incyte Corporation
-2.29% 13.79B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.21% 11.51B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+188.83% 10.9B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-53.94% 9.27B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 000518 Stock
  4. Financials Jiangsu Sihuan Bioengineering Co., Ltd